United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

biomarin europe ltd - sapropterin dihydrochloride - soluble tablet - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

biomarin europe ltd - amifampridine phosphate - tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

biomarin europe ltd - elosulfase alfa - solution for infusion - 1mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

biomarin europe ltd - cerliponase alfa - solution for infusion - 30mg/1ml

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - laronidase 0.58 mg/ml (rch) - concentrate for infusion - 500 u/5ml - active: laronidase 0.58 mg/ml (rch) excipient: dibasic sodium phosphate monohydrate monobasic sodium phosphate monohydrate polysorbate 80 sodium chloride water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - elosulfase alfa 1 mg/ml;   - concentrate for injection - 1 mg/ml - active: elosulfase alfa 1 mg/ml   excipient: arginine hydrochloride monobasic sodium phosphate monohydrate polysorbate 20 sodium acetate trihydrate sorbitol water for injection - treatment of mucopolysaccharidosis type iva (mps iva; morquio a syndrome) in children and adults of all ages.

Israel - English - Ministry of Health

medison pharma ltd - galsulfase - concentrate for solution for infusion - galsulfase 1 mg/ml - galsulfase - galsulfase - naglazyme is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of mpsvi (n-acetylglactosamine 4 sulfatase deficiency maroteaux-lamy syndrome).

Australia - English - Department of Health (Therapeutic Goods Administration)

merck serono australia pty ltd - sapropterin dihydrochloride -

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: sanofi-aventis philippines, inc.; distributor: sanofi-aventis philippines, inc. - laronidase - concentrated solution for iv infusion - 580 mcg/ml (2.9 mg/5 ml)

Canada - English - Health Canada

sanofi genzyme, a division of sanofi-aventis canada inc - laronidase - solution - 0.58mg - laronidase 0.58mg - enzymes